WHO ICTRP trial
Statins for Digital Ulcers and Raynaud's Phenomenon in systemic sclerosis
ISRCTN26319635 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN26319635 |
|---|---|
| Public title | Statins for Digital Ulcers and Raynaud's Phenomenon in systemic sclerosis |
| Scientific title | Statins: a potentially useful therapeutic option in the management of systemic sclerosis-related Raynaud's phenomenon and digital ulcers |
| Primary sponsor | University of Alexandria (Egypt) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Egypt |
| Conditions | Systemic Sclerosis (SSc) Musculoskeletal Diseases Systemic sclerosis |
| Interventions | The patients are divided into 2 groups: Group 1: assigned to receive 40 mg/day of atorvastatin for four months Group 2: assigned to identical placebo tablets for four months Seventy-five healthy age-sex-matched volunteers serve the purpose… |
| Registration date | Oct 12, 2007 |
| Target size | 80 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: